Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Can In-Licensing Models Substitute for Discovery?

Apr 01 2003

• By Michael Lytton

Related Content

GSK Ventures: Recycling R&D Assets

Feb 01 2003

Related Companies

The Medicines Company

King Pharmaceuticals, Inc.

Avera Pharmaceuticals, Inc.

Gilead Sciences, Inc.

Wyeth

Neurocrine Biosciences, Inc.

Pfizer Inc.

Spectrum Pharmaceuticals, Inc.

GPC Biotech AG

Johnson Matthey Plc

Bristol Myers Squibb Company

Cubist Pharmaceuticals, Inc.

Eli Lilly and Company

Johnson & Johnson

Momenta Pharmaceuticals, Inc.

Neose Technologies

Additional Topics

Strategy Business Strategies Leadership Platform Technologies BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window